SFX by Ex Libris Inc.

Title:	No evidence of association between genetic variants of the PDCD1 ligands and SLE
Source:	Genes and Immunity [1466-4879] Abelson, A K yr:2006

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Baca, V. "Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population." Genes and immunity 7.8 (2006): 693-5.
description	2.	Mataki, N. "Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases." The American journal of gastroenterology 102.2 (2007): 302-12.
description	3.	Eke, Ahizechukwu C. "Hepatitis B immunoglobulin during pregnancy for prevention of mother‐to‐child transmission of hepatitis B virus." Cochrane Database of Systematic Reviews 2.2.
description	4.	Grant, Charlotte R. "Regulatory T-cells in autoimmune diseases: Challenges, controversies and-yet-unanswered questions." Autoimmunity reviews 14.2 (2014): 105-116.
description	5.	Wang, Shu-Chen C. "Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in taiwan." Journal of clinical immunology 26.6 (2006): 506-11.
description	6.	Wang, S. "Ligands for programmed cell death 1 gene in patients with systemic lupus erythematosus." The Journal of rheumatology 34.4 (2007): 721-5.
description	7.	Sun, J. "PD-L1 expression analysis in gastric carcinoma tissue and blocking of tumor-associated PD-L1 signaling by two functional monoclonal antibodies." Tissue antigens 69.1 (2006): 19-27.
description	8.	Hasler, P. "Biological therapies directed against cells in autoimmune disease." Springer seminars in immunopathology 27.4 (2006): 443-56.
description	9.	Chen, G. "Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis." Hepatology 66.1 (2017): 13-26.
description	10.	Abu Raya, B. "Pertussis and influenza immunisation during pregnancy: a landscape review." The Lancet infectious diseases. 17.7.
description	11.	Kang, G. "Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers." Vaccine 33.33 (2015): 4093-9.
description	12.	Tseng, Y. "Infantile Hepatitis B in Immunized Children: Risk for Fulminant Hepatitis and Long-Term Outcomes." PLoS ONE 9.11 (2014): 1-8.
description	13.	Aubry, Marie C. "Tumor B7-H1 and B7-H3 Expression in Squamous Cell Carcinoma of the Lung." Clinical lung cancer 14.2 (2013): 157-163.
description	14.	Kijlstra, A. "CD41+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation." Investigative ophthalmology & visual science 47.10 (2006): 4444-52.
description	15.	Vanasek, T L L. "Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in the regulation of clonal anergy: enhanced cell cycle progression promotes recall antigen responsiveness." The journal of immunology 167.10 (2001): 5636-44.
description	16.	Hamanishi, J. "Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer." Proceedings of the National Academy of Sciences of the United States of America 104.9 (2007): 3360-5.
description	17.	Homann, D. "Regulatory T cells and type 1 diabetes." Clinical immunology 112.3 (2004): 202-9.
description	18.	Vignali, Dario A A A. "The development and function of regulatory T cells." Cellular and molecular life sciences 66.16 (2009): 2603-22.
description	19.	Blank, C. "Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion." Cancer immunology, immunotherapy 56.5: 739-45.
description	20.	Roncarolo, Maria-Grazia G. "Is FOXP3 a bona fide marker for human regulatory T cells?" European journal of immunology 38.4 (2008): 925-7.